Oral terbutaline for the treatment of priapism.

Abstract

The widespread use of penile injections in the management of erectile dysfunction has led to an increased incidence of priapism. It has been suggested that terbutaline, a beta-agonist, might be beneficial in treating priapism in this setting. We randomized 24 patients with prolonged erections to a prospective, double-blind, placebo-controlled trial. We did not find any benefit of oral terbutaline over placebo in these patients.

• Authors: F E Govier, E Jonsson, D Kramer-Levien
• Journal: The Journal of urology (J Urol) Vol. 151 Issue 4 Pg. 878-9 (Apr 1994) ISSN: 0022-5347 [Print] United States
• PMID: 8126815 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)

Chemical References

• Terbutaline

Topics

• Administration, Oral
• Double-Blind Method
• Humans
• Male
• Priapism (drug therapy)
• Prospective Studies
• Terbutaline (administration & dosage, therapeutic use)